CVI Investments, Inc. 13D and 13G filings for Caladrius Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:27 pm Sale | 2021-12-31 | 13G | Caladrius Biosciences, Inc. CLBS | CVI Investments, Inc. | 105,000 2.600% | -95,000 (-47.50%) | Filing |
| 2021-02-24 10:23 am Purchase | 2021-02-12 | 13G | Caladrius Biosciences, Inc. CLBS | CVI Investments, Inc. | 200,000 5.100% | 200,000 (New Position) | Filing |